Article Text

This article has a correction. Please see:

Download PDFPDF
Featured correspondence
  1. Paolo Alboni
  1. Correspondence to Dr Paolo Alboni, Division of Cardiology, Ospedale Civile, Cento (FE), Italy; p.alboni{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Authors' reply We thank Drs Kirchhof, Crijns and van Gelder1 for their interest in our paper2 referring to pill-in-the-pocket treatment of recent-onset atrial fibrillation (AF). The study was interrupted on the recommendation of the data- and safety-monitoring committee because the results suggested that the intravenous administration of flecainide or propafenone does not predict the occurrence of adverse effects after a loading oral dose of these drugs. A 5% incidence of major side effects during the first out-of-hospital treatment was regarded as high, considering that such patients have haemodynamically well-tolerated episodes of AF. All the …

View Full Text


  • Linked articles 217596.

  • Competing interests None.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Linked Articles

  • PostScript
    Charles J H J Kirchhof H J G M Crijns I C van Gelder
  • PostScript
    BMJ Publishing Group Ltd and British Cardiovascular Society